Skip to main content

Pharmacogenomics Hub in a strengthened IMGGE

Project description

Introduction of pharmacogenomics into clinical practice

Adverse drug reactions kill hundreds of thousands of patients every year in Europe alone. Hence the development of pharmacogenomics (PGX) to personalise therapies to improve the outcomes of the treatments is of great importance. The EU-funded PharmGenHUB project will support the effort of several university partners, coordinated by the Institute of Molecular Genetics and Genetic Engineering at the University of Belgrade in Serbia to develop PGX diagnostics, education, training, and translation of PGX knowledge into digital solutions for medical applications in the Western Balkans (WB) region. The project will employ high-throughput DNA sequencing to identify WB-specific drug-PGX marker pairs and to design electronic tools for treatment individualisation in clinical practice.

Coordinator

INSTITUT ZA MOLEKULARNU GENETIKU I GENETICKO INZENJERSTVO
Net EU contribution
€ 723 750,00
Address
Vojvode Stepe 444a
11010 Beograd
Serbia

See on map

Region
Србија - север Београдски регион Београдска област
Activity type
Research Organisations
Other funding
€ 0,00

Participants (3)

PANEPISTIMIO PATRON
Greece
Net EU contribution
€ 260 500,00
Address
University Campus Rio Patras
265 04 Rio Patras

See on map

Region
Αχαΐα Δυτική Ελλάδα Κεντρική Ελλάδα
Activity type
Higher or Secondary Education Establishments
Other funding
€ 0,00
UNIVERZA V LJUBLJANI
Slovenia
Net EU contribution
€ 145 000,00
Address
Kongresni Trg 12
1000 Ljubljana

See on map

Region
Slovenija Zahodna Slovenija Osrednjeslovenska
Activity type
Higher or Secondary Education Establishments
Other funding
€ 0,00
UNIVERSITA DEGLI STUDI DI TRIESTE
Italy
Net EU contribution
€ 210 000,00
Address
Piazzale Europa 1
34127 Trieste

See on map

Region
Nord-Est Friuli-Venezia Giulia Trieste
Activity type
Higher or Secondary Education Establishments
Other funding
€ 0,00